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Abstract: 
 
Introduction: Apolipoprotein E (ApoE) genotype and aerobic fitness are each associated with 
cognitive performance in older adults. However, their potentially interactive effects on cognitive 
performance have not been examined. Purpose: The primary purpose of this study was to 
determine whether ApoE genotype and aerobic fitness interact to uniquely 
impact memory performance and executive functioning. A secondary purpose was to examine 
the interactive effects on other measures of cognition to provide a more comprehensive 
assessment of cognitive abilities across a broad range of functions. Methods: Community-
dwelling, cognitively normal older women (N = 90) provided blood samples to allow for 
assessment of ApoE genotype, completed cognitive tests, and performed a maximal aerobic 
fitness test. Primary outcome variables were the auditory verbal learning test (AVLT), the 
complex figures test (CFT), and the Wisconsin card-sorting task (WCST). Secondary outcome 
variables were the block design test and the paced auditory serial addition task (PASAT). 
Results: Regression analyses indicated that aerobic fitness was associated with significantly 
better performance on measures of the AVLT, the CFT, and the PASAT for the ApoE-ε4 
homozygotes. Conclusion: The preliminary findings from this study support the possibility that 
aerobic fitness is positively associated with the memory performance of those individuals at most 
genetic risk for Alzheimer disease. 
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Article: 
 
Apolipoprotein E (ApoE) genotype is an important risk factor for Alzheimer disease (AD) (13,33). 
The presence of the ApoE-ε4 allele is negatively correlated with the cognitive abilities of aging, 
nondemented individuals (6,9,17,40) and is an important predictor of the development of AD 
(13,27,33). Additionally, longitudinal studies have shown that nondemented older carriers of the 
ApoE-ε4 allele have a greater rate of decline in cognitive functioning over time than do 
noncarriers of this allele (17,26,40). More recently, longitudinal studies of cognitively normal 
ApoE-ε4 carriers have also shown a steeper rate of memory decline than noncarriers (3,9). 
 
However, although the ApoE-ε4 allele has been found to be correlated with age-related cognitive 
declines and dementia, ApoE-ε4 does not, by itself, determine these negative cognitive 
outcomes. In population-based samples, researchers have found various rates of AD in ApoE-ε4 
homozygotes ranging from 15% (20) to 55% of those reaching 80 yr of age (27). Thus, although 
ApoE-ε4 homozygosity confers an increased risk of cognitive impairment with advancing age, 
other factors may also influence individual susceptibility (20). 
 
One variable that may influence the relationship between ApoE-ε4 and cognition is aerobic 
fitness. Cross-sectional research has generally shown that older adults who are more aerobically 
fit perform better on particular cognitive tasks than do those who are less fit (16). Although no 
published study to date has examined the potentially interactive effects of aerobic fitness and 
ApoE genotype, there are four published studies in which interactive effects between physical 
activity and ApoE genotype have been tested. 
 
Schuit et al. (35) assessed physical activity, cognitive function, and ApoE genotype in 347 older 
men at baseline and then assessed cognitive function again 3 yr later. Results indicated that the 
risk for cognitive decline was greater for inactive ApoE-ε4 carriers compared with physically 
active ApoE-ε4 carriers, but that physical activity did not impact the risk for cognitive decline in 
ApoE-ε4 noncarriers. Rovio et al. (32) reported data from 1449 people who were tested once 
during middle age (mean age = 50.6 yr) and again as older adults (mean age = 71.6 yr). Results 
demonstrated that physical activity was generally protective against dementia and AD for ApoE-
ε4 carriers, but not for ApoE-ε4 noncarriers. Lindsay et al. (24) conducted diagnostic tests to 
assess AD status at baseline and at a 5-yr follow-up in 4615 older adults. Results indicated that 
participants who reported regular participation in physical activity had a 31% reduction in the 
risk of AD compared with nonexercisers, but this risk was not modified by ApoE-ε4 status. 
Recently, Podewils et al. (29) examined the relationship between physical activity and the 
experience of dementia during a period of 5.4 yr in 3375 older adults. Their results indicated that 
individuals in the highest quartile for energy expenditure and individuals engaging in the most 
physical activities were at the lowest risk of dementia (RR = 0.85, 0.51, respectively). In direct 
contrast to Schuit et al. (35) and Rovio et al. (32), when examined relative to ApoE genotype, 
Podewils et al.'s (29) results indicated that theseassociations were only protective in the ApoE-ε4 
noncarriers and were nonsignificant for the ApoE-ε4 carriers. 
 
Although the conflicting findings of these studies are likely to be related to the variability in 
experimental designs, the different outcome variables, and the uniqueness of the samples, they 
are also likely to be a function of the methods used to assess physical activity. A limitation of all 
of these studies is that self-report measures were used to assess physical activity. Although self-
report measures with established psychometrics exist for older adults, three of these studies 
(24,32,35) used measures of physical activity that do not have reported psychometrics, and the other 
study (29) used a measure that was not designed specifically for older adults. Thus, the 
assessment of physical activity in all of these studies was less than optimal, and this might have 
contributed to the inconsistency of the findings. 
 
A second limitation of three of the four previous studies is that the participants were categorized 
only as ApoE-ε4 carriers or noncarriers, and the number of ε4 alleles was not considered. Given 
that there is evidence of a dose-response relationship between the number of ApoE-ε4 alleles and 
cognitive outcomes (17,40), and given the conflicting findings of the previously described studies 
relative to which group (carriers or noncarriers) benefits from being physically active, it was 
deemed prudent in this study to examine ApoE-ε4 status relative to the actual number of ε4 
alleles rather than to reduce this variable to a dichotomy. 
 
The purpose of this study was to examine the relationship between aerobic fitness and cognitive 
performance relative to the number of ApoE-ε4 alleles. The hypotheses for this study were based 
on the cognitive reserve hypothesis (37) with task-specific predictions based on the findings of 
the extant literature (6-8,12). The cognitive reserve hypothesis states that a person's cognitive 
reserve is predictive of the maintenance of cognitive performance with advancing age and is 
ultimately predictive of the risk of experiencing dementia (18). The variables that contribute to a 
person's cognitive reserve have been suggested to include both passive (e.g., cerebral structure) 
and active (e.g., use of efficient neural networks) components (36,39). As applied to AD, the 
hypothesis suggests that older predemented individuals who are at most genetic risk for AD 
(ApoE-ε4 homozygotes) would have the least cognitive reserve and, thus, would be at the 
highest risk for cognitive declines and dementia. The cognitive reserve hypothesis further posits 
that cognitive reserve is enhanced by a variety of lifestyle factors including formal education, 
occupational complexity, and physical activity (18,37,39). Thus, on the basis of the cognitive 
reserve hypothesis, and because the sample for this study consisted of predemented adults, it was 
predicted that aerobic fitness would interact with ApoE status such that the positive relationship 
between aerobic fitness and cognitive performance would be most evident in the ApoE-ε4 
homozygotes. Given previous findings of significant interactive effects of ApoE-ε4 status on 
measures of verbal memory relative to fatigue (8) and age(6) and the meta-analytic findings that 
aerobic fitness effects are largest for tasks that assess executive functioning (12), we hypothesized 
that the interaction effects would be evident for the tasks assessing verbal memory and executive 
functioning. 
 
METHODS 
 
Participants 
 
Community-dwelling older women were recruited from Maricopa County, AZ using two 
methods. Men were not recruited for participation because the ApoE-ε4 allele has a greater effect 
on the cognitive performance of women than men (20) and because physical activity has been 
found to have a greater protective effect for the cognitive performance of older women (22). 
Letters of invitation were sent to 151 women who were actively participating in an ongoing 
study at the Mayo Clinic Scottsdale; 58 of these women agreed to complete the procedures 
required for inclusion in this ancillary study. Participants in the Mayo Clinic study were recruited 
into the longitudinal study with advertisements requesting volunteers with a family history of 
AD for a longitudinal study relative to AD. They were subsequently recruited for participation in 
this study with a letter of invitation that requested their participation in a study designed to look 
at the relationship between physical fitness and cognitive performance. An additional 44 
participants were recruited from the general population using newspaper advertisements 
requesting volunteers for a study on physical fitness and cognition relative to AD. From this 
sample (N = 102), several participants could not be included in the final data analyses; six were 
excluded because they had not completed the V˙O2max test, and two were excluded because they 
met exclusion criteria for the Hamilton rating scale for depression (HRSD). Thus, the final 
sample consisted of 94 women (51-81 yr, mean = 62.00, SD = 7.39) and could be described as 
predominantly married (67%), Caucasian (93%), college educated (54%), retired (52%), and 
postmenopausal (97%). On the basis of the average V˙O2peak values (mean = 22.57) and 
normative data (1), and on the basis of self-reported physical activity levels (mean = 7.36) and 
cutoff scores proposed by Buchheit et al. (5), the sample could also be described as relatively 
low-fit and sedentary. 
 
Exclusion Criteria 
 
The exclusion criteria included conditions that would preclude performance of the graded 
exercise test (including functional limitations, use of medications that would suppress blood 
pressure or heart rate during the test, severe symptomatic heart disease); confounding 
neurological or medical concerns (including psychiatric illness, Parkinson disease, traumatic 
brain injury, prior stroke, active treatment for cancer, hearing impairments, alcoholism, use of 
medications to treat conditions of AD, and uncorrected visual problems); clinical depression (≥ 
10 on the HRSD); and an inability to speak English. Additionally, participants were excluded if 
they met published criteria for age-associated memory impairment (14), mild cognitive 
impairment (28), AD (25), or any other form of dementia (2), or if they scored less than 27 on the 
MMSE based on published norms relative to the average age and education of this sample (15). 
 
Assessment of Demographic Variables 
 
Height and weight were assessed and body mass index was calculated. Participants were asked to 
report their race, education, marital status, employment status, and menopausal status. Physical 
activity was self-reported using the modified Baecke questionnaire, which has established 
reliability and validity (38). 
 
Assessment of Statistical Covariates 
 
Given that some of the participants were enrolled in the ongoing longitudinal study at the Mayo 
Clinic, there was variability in the amount of time that passed between cognitive testing and the 
graded exercise test. Thus, time between testing was examined as a potential confounding 
variable. Additional extraneous variables considered were education, age, use of nonsteroidal 
antiinflammatory medications (current user, past user, never user), use of vitamin E (current 
user, past user, never user), use of hormone-replacement therapy (current user, past user, never 
user), depressive symptoms (Beck depression inventory), and general cognitive ability (mini-
mental status exam). These potentially confounding variables were used as statistical covariates 
if they showed significant differences as a function of ApoE genotype or if they correlated with 
aerobic fitness. Additionally, to test for a possible ascertainment bias, cohort (recruited from 
ongoing Mayo Clinic study, recruited from general public) was entered as a covariate in the 
regression analyses and did not have a meaningful impact on the results; therefore, all results are 
presented without consideration of cohort. 
 
Assessment of Dependent Variables 
 
The cognitive tests examined were designed to assess performance across the cognitive domains 
that have been shown to be characteristically sensitive to the early stages of dementia (23). All of 
these tests have been used extensively in the literature and have well-understood psychometric 
properties. The primary outcome measures were a test of verbal memory (the auditory verbal 
learning test (AVLT)) and an executive function test (the Wisconsin card-sorting test (WCST)). 
Tests sensitive to other cognitive domains were considered secondary outcome measures. 
 
Primary Outcomes Measures 
 
AVLT. The AVLT was used as a measure of verbal memory. Participants are presented with a 
list of 15 words (List A) during five learning trials. They are then presented with and asked to 
recall words from a distracter list (List B). Immediately after this, participants are asked to recall 
the List A words (short-term memory). Lastly, after performing other tasks for 30 min (± 5 min), 
participants are asked to again recall the List A words (long-term memory). Scores examined 
included the number of words recalled at trial 1, the number of words recalled at trial 5, the total 
number of words recalled across all five trials (total learning), the number of words from List A 
recalled after the presentation of the List B words (short-term memory), and the number of words 
recalled after the 30-min delay (long-term memory). 
 
WCST. The WCST requires participants to discern a sorting principle that is being used to 
determine the accuracy of their responses. Participants have a stack of response cards and are 
instructed to place one of the response cards under the key card that they think it matches. The 
four key cards are one red triangle, two green stars, three yellow plus signs, and four blue circles. 
The response cards represent all possible combinations of these shapes, colors, and number of 
shapes. The sorting principle is color, shape, or number. After placing a response card, the 
participant is given feedback by the experimenter as to whether it is correct and is instructed to 
use the feedback to figure out the sorting principle for the next card. This test assesses concept 
formation and reasoning abilities (23) and is considered to be a measure of executive functioning. 
 
Secondary Cognitive Outcomes 
 
Rey-Osterreith complex figures test (CFT). Participants are asked to copy a complex two-
dimensional figure while looking at it. After a delay period, participants are asked to draw the 
figure from memory. This test is used to assess delayed visual memory and constructional praxis. 
The ratio of the score on the recall task relative to the copy task provides an index of the percent 
savings and is the measure of performance used in this study. 
 
Block design task. The block design task of the Wechsler adult intelligence scale (revised) is a 
timed test that requires that participants use colored blocks to replicate patterns provided for 
them. This test assesses perceptual and constructional skills. 
 
Paced auditory serial addition task (PASAT). Participants are read a series of single-digit 
numbers and are then asked to sequentially add pairs of these numbers and to respond with the 
appropriate sums. On this task, participants who refused to perform the task or who failed the 
trial items were scored as missing data because their comprehension of the task was never 
demonstrated. This task is indicative of selective attention, information processing, and 
working memory. 
 
Assessment of Independent Variables 
 
Aerobic fitness. Before the graded exercise test (GXT), electrodes were applied for the 
measurement of electrocardiographic (ECG) activity, and participants sat in a chair for the 
resting measures of ECG and blood pressure. Participants were supervised by a physician during 
and after the GXT. 
 
The GXT was performed on a treadmill using the modified Naughton protocol (4) with a goal of 
obtaining a maximal measure of fitness. Participants wore a face mask, and expired gases were 
collected by a Parvo-Medics True Max 2400 metabolic cart. Oxygen consumption was measured 
using indirect calorimetry. A maximal effort was considered to be achieved if two of three 
standard criteria were met. These criteria are 1) a plateau (increase of < 3 mL·kg−1·min−1) in 
V˙O2 with an increase in workload, 2) a respiratory exchange ratio of 1.1 or greater, or 3) a heart 
rate (HR) within 10 beats of the age-predicted maximal HR. Nine of our participants did not 
meet two of the three criteria necessary for a maximal effort; therefore, the measure of aerobic 
fitness that is reported is V˙O2peak. 
 
ApoE genotype. A venous blood draw was taken. Genetic determination of ApoE allelic status 
was performed using a polymerase chain reaction (PCR)-based assay (19). 
 
Procedures 
 
Potential participants completed a telephone interview to ascertain exclusion criteria. Participants 
came to the laboratory on three different days. The procedures and consent forms for this study 
were approved by the Mayo Clinic and the Arizona State University institutional review boards. 
Before testing, participants read and signed an informed consent that stated that they would not 
receive information regarding their ApoE genotype. On the first day, participants completed 
several measures necessary for identifying their status relative to the exclusion criteria. They 
completed a medical history, a neurologic examination, the Folstein mini-mental status exam, the 
HRSD, and the Beck depression inventory, and they provided a blood sample for ApoE 
assessment. On the second day, participants performed the cognitive tests that served as the 
dependent variables in this study. On the third day, height and weight were measured, and then 
participants completed the GXT. During all testing, experimenters were blinded to information 
(i.e., genotype, fitness level) that could bias their objectivity. 
 
Statistical Analyses 
 
Chi-square analyses and one-way analyses of variance (ANOVA) were conducted to determine 
whether the ApoE subgroups were equivalent with respect to potentially confounding variables, 
and correlations were conducted between potential confounds and V˙O2peak. 
 
Hierarchical linear regression analyses were conducted to test the effects of aerobic fitness, 
ApoE genotype, and their interaction on the dependent variables of interest. The number of 
ApoE-ε4 alleles (0, 1, 2) was dummy coded. To aid with interpretation of significant 
interactions, V˙O2peak was centered for the sample (11). Identified confounds were statistically 
controlled by entering them in the first step of the regression. Main effects for ApoE-ε4 number 
and V˙O2peak were entered in the second step. The interaction of V˙O2peak by ApoE-ε4 number 
was entered in the third step. Before the results were interpreted, regression diagnostics were 
conducted to examine the effects of potential outliers. Specifically, leverage, discrepancy, and 
global and specific influence values were examined for all regressions (11). When data points 
were identified as of concern, regression analyses were recomputed with the outliers removed. 
These instances are noted, and results are presented from the original analyses. After 
identification of significant interactions, simple regression analyses were conducted to identify 
the groups for which the relationship between aerobic fitness and the criterion was significant. 
Power analyses were conducted for the interaction effects, using the methods of Cohen (10). 
 
Given the a priori hypotheses regarding the nature of the effects, adjustments were not made for 
experiment-wise inflation of alpha, and all analyses were conducted at α= 0.05. 
 
 
RESULTS 
 
Descriptive Statistics 
 
Descriptive statistics for the sample are provided in Table 1. 
 
Potential Confounds 
 
Chi-square analyses showed that there were no significant differences among the genotypes on 
reported use of hormone-replacement therapy, χ2 = 5.51 (df = 4, N = 92); nonsteroidal 
antiinflammatory medications, χ2 = 1.96 (df= 4,N = 94); or vitamin E, χ2 = 9.06 (df = 4, N=94). 
ANOVA indicated that there were also no significant differences among the genotypes on any of 
the following variables: time between tests, F(2, 91) = 0.15; depressive symptoms, F(2, 91) = 
1.76; age, F(2, 91) = 0.40; education, F(2, 90) = 0.74, or MMSE, F(2, 91) = 0.97, P>0.05 
(see Table 1 for means and standard deviations). However, age was significantly negatively 
correlated with V˙O2peak (r = −0.51, P < 0.001). Therefore, age was statistically controlled for in 
all regression analyses. 
 
Regression Analyses 
 
F statistics, R2 values, and the statistical power of the interactions are presented in Table 2. 
 
 
TABLE 1: Descriptive statistics for the sample relative to ApoE-ε4 genotype. 
 Noncarriers 
(N = 59) 
Mean (SD) 
Heterozygotes 
(N = 27) 
Mean (SD) 
Homozygotes 
(N = 8) 
Mean (SD) 
Total Sample 
(N = 94) 
Mean (SD) 
Age (yr) 61.81 (7.34) 61.74 (7.46) 64.25 (8.21) 62.00 (7.39) 
MMSE 29.75 (0.71) 29.85 (0.36) 29.50 (0.76) 29.76 (0.63) 
HRSD 1.80 (2.25) 1.11 (1.65) 2.63 (2.97) 1.67 (2.18) 
Beck depression inventory 4.51 (3.71) 3.19 (2.24) 5.25 (4.83) 4.19 (3.49) 
VO2peak (mL•kg-1•min-1) 23.41 (5.32) 20.53 (4.41) 23.21 (5.28) 22.57 (5.18) 
Body mass index (kg•m2) 25.29 (4.18) 25.59 (4.09) 26.06 (4.18) 25.44 (4.11) 
Time lag (d) 34.10 (174.02) 15.56 (135.34) 49.50 (315.26) 30.09 (177.74) 
Educationa (yr) 15.43 (2.17) 16.00 (2.27) 15.25 (1.75) 15.58 (2.16) 
Physical activity 7.98 (5.30) 6.05 (5.14) 7.29 (3.70) 7.36 (5.17) 
AVLT trial 1 6.10 (1.35) 6.78 (1.85) 6.75 (2.49) 6.35 (1.63) 
AVLT trial 5 12.25 (1.79) 12.96 (1.81) 11.38 (3.70) 12.38 (2.03) 
AVLT total learning 48.86 (7.92) 52.15 (9.36) 50.38 (14.46) 49.94 (9.03) 
AVLT short-term memory 9.54 (2.55) 10.22 (3.19) 10.13 (3.72) 9.79 (2.84) 
AVLT long-term memory 9.27 (2.82) 9.56 (3.60) 9.38 (4.50) 9.36 (3.18) 
WCST categoriesa 5.33 (1.37) 5.11 (1.76) 4.13 (2.36) 5.16 (1.60) 
WCST errorsa 27.07 (17.52) 28.96 (19.95) 38.38 (18.49) 28.59 (18.40) 
WCST perseverative errorsa 13.38 (8.84) 14.19 (9.54) 18.75 (9.62) 14.08 (9.13) 
CFT ratio 0.50 (0.17) 0.54 (0.18) 0.60 (0.29) 0.52 (0.19) 
Block design 11.92 (2.42) 12.67 (2.54) 12.50 (2.56) 12.18 (2.46) 
PASAT*b 47.24 (9.73) 49.78 (8.43)a 38.25 (16.82)b 47.20 (10.47) 
MMSE, mini-mental status exam; HRSD, Hamilton rating scale for depression; AVLT, auditory verbal learning test; 
WCST, Wisconsin card-sorting test; CFT, complex figures test; PASAT, paced auditory serial addition task. a N = 58 
for noncarriers; b N = 55 for noncarriers. * Significant difference as a function of ApoE genotype (P < 0.05). Values 
with different superscripts are significantly (P < 0.05) different from one another according to a Tukey’s post hoc 
analysis. 
 
TABLE 2: Statistical results from the regression analyses. 
 Covariate Main Effects Interaction Effects Power to Detect 
Information Cognitive Variable F(1,92) R2 F(3,89) R2 F(2,87) R2 
AVLT trial 1 11.52*** 0.11 1.83 0.05 2.07 0.04 0.34 
AVLT trial 5 12.78*** 0.12 1.77 0.05 5.25** 0.09 0.72 
Trial 5, with four outliers removed 11.05*** 0.11 0.95 0.03 7.21*** 0.13 0.84 
AVLT total learning 12.83*** 0.12 1.72 0.05 2.52 0.05 0.41 
AVLT short-term memory 8.83** 0.09 1.19 0.04 1.95 0.04 0.33 
AVLT long-term memory 8.73** 0.09 0.27 0.01 2.79 0.06 0.45 
WCST categoriesa 2.72 0.03 1.25 0.04 0.71 0.02 0.13 
WCST errorsa 2.56 0.03 0.91 0.03 0.44 0.01 0.09 
WCST perseverative errorsa 2.33 0.03 0.91 0.03 0.35 0.01 0.07 
CFT 12.62*** 0.12 1.36 0.04 4.97** 0.09 0.70 
CFT with two outliers removed 10.11** 0.10 0.83 0.03 4.06* 0.08 0.60 
Block design 0.00 0.00 1.41 0.05 2.74 0.06 0.44 
PASATb 0.71 0.01 2.67 0.09 6.57** 0.12 0.81 
PASAT with five outliers removed 0.15 0.00 8.94*** 0.25 4.36* 0.08 0.51 
AVLT, auditory verbal learning test; WCST, Wisconsin card-sorting test; CFT, complex figures test; PASAT, paced 
auditory serial addition task. a Error df value is one less than standard because of missing data; b error df value is four 
less than standard because of missing data; covariate = age; main effects = aerobic fitness and genotype; interaction 
effects = aerobic fitness by genotype. Degrees of freedom in the denominator for analyses with outliers removed 
should be reduced by the number of outliers removed. * P < 0.05; ** P < 0.01; *** P < 0.001. 
 
Primary Outcome Variables 
 
AVLT. For all measures, the main effect for age was a significant predictor of performance, 
indicating that age was negatively related to performance on trial 1 (β = −0.33), performance on 
trial 5 (β = −0.35), total learning (β = −0.35), short-term memory (β = −0.30), and long-
term memory (β = −0.29). However, neither the main effect for fitness nor the main effect for 
genotype contributed further to the explained variance. 
 
For performance on trial 5, the interaction of fitness by genotype did add significantly to the 
explained variance (P< 0.01). Examination of the regression diagnostics indicated that four data 
points were of concern. When these four data points were omitted, the interaction term remained 
a significant predictor (P < 0.001) and the nature of the interaction did not change. Simple 
regression analyses with the complete data set indicated that aerobic fitness was a significant 
predictor of performance for the ApoE-ε4 homozygotes (β = 0.71, R2 = 0.50) but not for the 
other two genotype groups (Fig. 1). 
 
 
FIGURE 1: The relationship between aerobic fitness and performance on trial 5 of the auditory 
verbal learning test (AVLT) relative to ApoE-ε4 genotype. The significant relationship for the 
ApoE-ε4 homozygotes is indicated by the presence of the line of bestfit. 
 
Although the interaction effect was not statistically significant for any of the other measures 
from the AVLT, there was a trend towards significance for total learning (P<0.09) and for long-
term memory (P < 0.07). An examination of the interactions demonstrated that the nature of the 
relationship was consistent with the results that were found for trial 5. 
 
WCST. None of the main effects or the interaction effect were significant predictors of WCST 
categories. Neither the main effects nor the interaction were significant for total errors or for 
perseverative errors. 
 
Secondary Outcome Variables 
 
CFT. The covariate and the interaction of fitness by genotype were significant predictors of 
performance (P < 0.01). Regression diagnostics indicated that two data points were of concern 
because of their high leverage values. When the regression analysis was repeated with these data 
points removed, the interaction term remained significant (P < 0.03) and the nature of the 
interaction effect did not change. Thus, results are reported from the complete data 
set.Regression coefficients indicated that age was negatively related to performance, β = −0.35. 
The simple regression analyses indicated that aerobic fitness was a significant positive predictor 
of performance for the homozygotes (β = 0.77, R2 = 0.60) but was not predictive of performance 
for the ApoE-ε4 heterozygotes and noncarriers (Fig. 2). 
 
 
FIGURE 2: The relationship between aerobic fitness and the recall-to-copy ratio of the complex 
figures test (CFT). The significant relationship for the ApoE-ε4 homozygotes is indicated by the 
presence of the line of best fit. 
 
Block design task. There were no significant predictors of performance. 
 
PASAT. The interaction of fitness by genotype was a significant predictor of performance (P < 
0.003). Regression diagnostics indicated that five data points were of concern. Omission of these 
data points from the analyses did notchange the results; the interaction term remained a 
significant predictor (P < 0.01). Results from the simple regressions with the complete data set 
showed that higher levels of aerobic fitness were predictive of significantly better performance 
for ApoE-ε4 homozygotes (β = 0.79, R2 = 0.63) but that the relationship was not meaningful for 
the other two groups (Fig. 3). 
 
 
FIGURE 3: The relationship between aerobic fitness and performance on the paced auditory 
serial addition task (PASAT). The significant relationship for the ApoE-ε4 homozygotes is 
indicated by the presence of the line of best fit. 
 
DISCUSSION 
 
This study was designed to examine the potentially interactive relationship between aerobic 
fitness and cognitive performance relative to ApoE-ε4 genotype. On the basis of the findings of 
the past literature (6,8,12,32,35) and the cognitive reserve hypothesis, it was hypothesized that 
aerobic fitness would be positively related to the performance of certain types of cognitive tasks 
for women at the highest genetic risk for AD. The preliminary findings of this study provided 
mixed support for this hypothesis, with the interaction term reaching statistical significance for 
one of our primary outcome memory tests (trial 5 of the AVLT) and showing a trend toward 
significance for two other measures from this test (total learning, long-term memory). This 
finding is consistent with those of past researchers who found these same AVLT measures to be 
sensitive to the interaction of age by ApoE genotype (6,9). The significant interactions for the 
PASAT and for the CFT were not specifically predicted, but they are logical because 
working memory is an important contributor to performance on both tasks. 
 
The failure of the interaction to impact performance on the WCST is surprising because 
measures of executive function have been demonstrated to experience the biggest effects relative 
to chronic exercise interventions (12), and past research has shown the WCST to be sensitive to 
interactions between chronic anxiety and ApoE status (7). Although the statistical analyses for 
these dependent variables were dramatically underpowered, it is important to note that the 
percentage of variance explained by the interaction term for these variables was negligible, 
which suggests that the interaction effects for these variables would not be meaningful even if 
the relationship were tested with a larger sample so that statistical significance might be 
achieved. The failure of the interaction effect to be demonstrated with the block design task is 
consistent with past research demonstrating that this cognitive task is not sensitive to the age-
ApoE status interaction (6). 
 
Importantly, the nature of all of the significant or nearly significant interactions was remarkably 
consistent. In general, aerobic fitness was a positive predictor of cognitive performance for the 
ApoE-ε4 homozygotes, but it did not explain a meaningful portion of the variance for the ApoE-
ε4 heterozygotes and the ApoE-ε4 noncarriers. The finding for the ApoE-ε4 homozygotes 
supports the cognitive reserve hypothesis in that the individuals at the highest risk for AD (who 
would be predicted to have the smallest cognitive reserves) demonstrated the greatest benefit 
from aerobic fitness (which would be predicted to increase cognitive reserves). Given the 
previously demonstrated dose-response relationship between ApoE-ε4 gene dose and cognitive 
outcomes (17,40), it may seem surprising that these same results were not evident for the ApoE-ε4 
heterozygotes. However, given that this sample consisted of physically healthy, cognitively 
normal individuals, it is likely that the cognitive reserves of the ApoE-ε4 heterozygotes were 
sufficiently high that the benefits of aerobic fitness were not evident. In other words, we are 
suggesting a threshold effect such that the beneficial effects of aerobic fitness for cognitive 
performance might not be apparent until a person's cognitive reserves have decreased to a certain 
threshold, and this threshold might be approached in cognitively normal ApoE-ε4 homozygotes. 
This interpretation is consistent with findings using neural imaging in which cognitively normal 
ApoE-ε4 homozygotes show patterns of cerebral function that may be indicative of subclinical 
incipient AD pathology (30,31,34). 
 
Before drawing conclusions from this study, there are limitations that must be acknowledged. 
First, there were only eight ApoE-ε4 homozygotes in the sample, thus potentially limiting the 
reliability and generalizability of the findings. However, when regression diagnostics were 
conducted and appropriate measures were taken for data points that were of concern, the findings 
remained essentially unchanged. In addition, the fact that the relationships were in the 
hypothesized direction and that the nature of the interactions was consistent across cognitive 
measures lends credence to the reliability of the findings. That being said, the findings of this 
study should be considered preliminary, and future research will be needed with a larger number 
of ApoE-ε4 homozygotes to ensure that the sample is representative of the population of 
homozygous older women and that these results are, in fact, reliable. A second caveat is that 
V˙O2peak is determined both by genetic factors and by behavioral variables, and this study was 
cross-sectional in design. Therefore, the relationship between V˙O2peak and cognitive 
performance in the ApoE-ε4 homozygotes may reflect other physiological mechanisms (e.g., 
lipid profiles, cerebral structure, availability of brain-derived neurotrophic factor) that are also 
partially genetically determined and that may be the causal mechanism underlying both the 
enhanced cognitive performance and the higher aerobic fitness. Third, because a cross-sectional 
design was used, it is possible that the individuals who maintained their cognitive abilities are 
also those who are capable of maintaining physical activity levels that keep their aerobic fitness 
high relative to the others in the sample. These last two limitations can only be addressed 
through the conductance of another study using an experimental design in which aerobic fitness 
is manipulated and changes in cognitive performance are examined relative to ApoE status. 
 
Despite the limitations of this study, our findings provide support for the old adage "healthy 
body, healthy mind" and suggest that aerobic fitness may be differentially beneficial to older 
adults, depending on their ApoE status, which may itself be reflective of the availability of 
cognitive reserves. Because higher levels of aerobic fitness were demonstrated to be positively 
associated with the cognitive performance of older adults at the highest genetic risk for AD, 
these individuals might experience some degree of protection of their cognitive abilities as a 
function of maintaining (or attaining) higher levels of aerobic fitness. If future research supports 
a causal relationship between aerobic fitness and cognitive performance for ApoE-ε4 
homozygotes, it is possible that the adoption of physical activity designed to improve aerobic 
fitness may ameliorate cognitive declines and delay the onset of AD for these individuals. Given 
that a behavioral therapy that can delay the experience of AD by 5 yr could reduce the risk of 
experiencing this disorder by 50% (21), this has important implications for future gene-related 
medical therapy that could be designed to particularly target those at genetic risk for cognitive 
declines, clinical impairment, and AD. 
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